Holen Sie sich die Stockscreener-App
16.91
2.32%
-0.5099
Schlusskurs vom Vortag:
$17.42
Offen:
$17.6
24-Stunden-Volumen:
20,045
Relative Volume:
0.02
Marktkapitalisierung:
$765.50M
Einnahmen:
$110.24M
Nettoeinkommen (Verlust:
$-66.44M
KGV:
-11.19
EPS:
-1.5111
Netto-Cashflow:
$-61.12M
1W Leistung:
-14.58%
1M Leistung:
+3.75%
6M Leistung:
+55.10%
1J Leistung:
-31.58%
1-Tages-Spanne:
$16.94
$17.67
1-Wochen-Bereich:
$17.10
$19.97
52-Wochen-Spanne:
$8.80
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
Firmenname
Beta Bionics Inc
Sektor
Branche
Telefon
949-427-7785
Adresse
11 HUGHES, IRVINE
Compare BBNX vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
17.02 | 869.65M | 110.24M | -66.44M | -61.12M | -1.5111 |
ABT
Abbott Laboratories
|
104.80 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.38 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
274.42 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.08 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.60 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Eingeleitet | UBS | Buy |
| 2026-01-27 | Eingeleitet | TD Cowen | Hold |
| 2026-01-09 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-10-21 | Fortgesetzt | Stifel | Buy |
| 2025-10-01 | Hochstufung | Goldman | Neutral → Buy |
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-06-12 | Eingeleitet | Lake Street | Buy |
| 2025-05-30 | Eingeleitet | Goldman | Neutral |
| 2025-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2025-02-24 | Eingeleitet | BofA Securities | Buy |
| 2025-02-24 | Eingeleitet | Lake Street | Buy |
| 2025-02-24 | Eingeleitet | Leerink Partners | Outperform |
| 2025-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-24 | Eingeleitet | Stifel | Buy |
| 2025-02-20 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2025-02-20 | Eingeleitet | Robert W. Baird | Neutral |
Alle ansehen
Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten
Kaplan Fox Reminds Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to a Securities Class Action DeadlineContact the Firm Before November 3, 2026 - FinancialContent
Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Contact the Firm to Learn About Their Legal Rights - FinancialContent
Beta Bionics Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
Insider plans to sell about $779K in Beta Bionics (NASDAQ: BBNX) stock - Stock Titan
BBNX Class Action Notice: Beta Bionics Sued for Securities Fraud After Allegedly Misleading Investors about the Safety of its Medical Device – Investors Urged to Contact BFA Law - Business Wire
Beta Bionics faces a securities lawsuit after F... - pluang.com
BBNX Shareholder Alert: November 3, 2026 Lead Plaintiff Deadline in Beta Bionics, Inc. Securities Class ActionContact Levi & Korsinsky - PR Newswire
Berger Montague PC Investigating Claims on Behalf of Investors in Beta Bionics, Inc. (BBNX) After Class Action Filing - marketscreener.com
BETA BIONICS, INC. (BBNX) INVESTOR ALERT Investors With Large Losses in Beta Bionics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights - Procurement Magazine
BBNX INVESTOR ALERT: Securities Class Action Filed Against Beta Bionics, Inc. – Investors Encouraged to Contact Kirby McInerney LLP - Business Wire
BBNX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Beta Bionics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
BBNX Investor Alert: Johnson Fistel Encourages Beta Bionics, Inc. Investors to Contact the Firm Ahead of November 3, 2026 Lead Plaintiff Deadline - lincolnjournal.com
BBNX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Beta Bionics (NASDAQ: BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026 - Bluefield Daily Telegraph
Class action lawsuit filed against Beta Bionics over faulty insulin pump issues. - Pluang
BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit - PR Newswire
BETA BIONICS, INC. (BBNX) INVESTOR ALERT Investors With - GlobeNewswire
BETA BIONICS, INC. (BBNX) INVESTOR ALERT Investors With Large Losses in Beta Bionics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights - GlobeNewswire Inc.
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - Business Wire
BBNX INVESTOR ALERT: Class Action Lawsuit Filed on Behalf - GlobeNewswire
Rosen Law Firm Urges Beta Bionics, Inc. (NASDAQ: BBNX) Stockholders to Contact the Firm for Information About Their Rights - Business Wire
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta ... - pmg-ky3.com
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files - GlobeNewswire
Class action lawsuit alleges Beta Bionics misled investors on FDA safety findings for its insulin pump. - pluang.com
BBNX Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Beta Bionics Inc. - PR Newswire
BBNX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Beta Bionics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges Beta Bionics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
Beta Bionics, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your Rights – BBNX - FinancialContent
Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders - Supply Chain Digital
Beta bionics CEO Sean Saint sells $113,258 in company stock By Investing.com - Investing.com India
Have Beta Bionics Insiders Been Selling Stock? - simplywall.st
Beta Bionics CFO Stephen Feider sells $127,579 in stock By Investing.com - Investing.com South Africa
Beta Bionics Faces Securities Class Action Lawsuit - stl.news
Beta bionics CEO Sean Saint sells $113,258 in company stock - Investing.com
Investor Alert: Robbins LLP Informs Investors of the Beta Bionics Inc. Class Action Lawsuit - FinancialContent
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit - FinancialContent
Beta Bionics CPO Mike Mensinger sells $83,619 in stock By Investing.com - Investing.com South Africa
Beta Bionics CEO Sean Saint Executes Sale of 5,641 Shares via 10b5-1 Trading Plan - Kalkine Media
Beta Bionics (BBNX) CEO sells 5,641 shares under preset plan - Stock Titan
Beta Bionics CCO Hopman Mark Disposes of 5,327 Shares at $19.11 Each (NASDAQ: BBNX) - Kalkine Media
Beta Bionics CEO Saint Sean Offloads 16,867 Shares at $19.11 Each (NASDAQ: BBNX) - Kalkine Media
Beta bionics CCO Mark Hopman sells $101,815 in stock By Investing.com - Investing.com South Africa
Beta Bionics CEO Sean Saint disposes of 5,641 common shares for $113,261.01 - Bitget
Beta Bionics CMO Russell sells $80,676 in company stock By Investing.com - Investing.com South Africa
President & CEO Sean Saint sells $322,380 in Beta Bionics stock - Investing.com Australia
Beta Bionics CMO Russell sells $80,676 in company stock - Investing.com India
Beta Bionics CPO Mike Mensinger Sells 4,375 Shares to Settle RSU Tax Withholding - kalkinemedia.com
Beta Bionics CMO Steven Jon Russell Sells 4,221 Shares to Cover RSU Tax Withholding - Kalkine Media
Beta Bionics CCO Mark Hopman Sells 5,327 Shares to Cover RSU Tax Withholding - Kalkine Media
Beta bionics CCO Mark Hopman sells $101,815 in stock - Investing.com
Beta Bionics CFO Stephen Feider sells $127,579 in stock - Investing.com
Beta Bionics (BBNX) CMO sells for taxes, holds 169K shares - Stock Titan
Finanzdaten der Beta Bionics Inc-Aktie (BBNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):